Loading clinical trials...
Loading clinical trials...
The purpose of this protocol is to obtain biologic samples from the blood and lungs from patients with lung diseases in order to study the causes and indications of these disorders, learn how these lu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
NCT07589439 · Asthma
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
NCT07011394 · Diagnosis, Inflammation, and more
NCT06023589 · Asthma
NCT05139719 · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Hamad Medical Corporation
Doha
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions